eG Innovations Announces Free, SaaS-Based Logon Simulator for VMware Horizon
eG Innovations, a leading IT performance management software provider, announced today the expansion of its free online eG Enterprise Express SaaS solution to help VDI-driven organizations quickly identify and remediate logon issues that negatively affect the user experience and business productivity. eG Enterprise Express Logon Simulator for Citrix and VMware Horizon now provides any VMware Horizon administrator with a no-risk, powerful “synthetic” monitoring tool to track logon performance, whether hosted on premise, in the cloud, or in a hybrid environment.
“Slow logon performance has been one of the most challenging user complaints that VDI administrators and support teams have to deal with,” said Srinivas Ramanathan, chief executive officer, eG Innovations. “When a user logs on to a virtual desktop, there are many interactions that need to occur between different infrastructure elements. A slow-down anywhere in the infrastructure – the VMware Connection Server, the vSphere ESX servers, VMware vCenter, storage, Active Directory, profile servers, etc. – can result in slow logons. VDI administrators must be able to detect such situations proactively and resolve them. 24x7 simulation and alerting on virtual desktop logon failures provides VDI administrators with exactly what they need to proactively detect and fix such issues, and thereby ensure a great user experience”.
With this new release, organizations can now use the eG Enterprise Express free logon simulator to monitor desktop and application virtualization infrastructures running on either VMware Horizon or Citrix XenApp and XenDesktop. eG Enterprise Express allows administrators to continuously simulate the exact same steps that users take to log on to the VMware Horizon environment. Administrators can receive real-time alerts, analyze performance over time and generate SLA reports using a web browser. A mobile app providing on-the-go access is also available. “We’re pleased to offer this capability as a free resource for VMware Horizon admins everywhere, to help make their job easier and improve their users’ experience” said Ramanathan.
This SaaS solution can be set up in minutes and is being offered free of charge forever. A simple website signup is the only requirement to get started.
- Synthetic logon simulation tool for monitoring, diagnosis, alerting and reporting of VMware Horizon logon performance
- Tracks every step of the Horizon logon process (browser access, authentication, enumeration, session establishment, and application launch), and pinpoints which step is causing logon slowdown
- Proactively diagnoses logon issues before users are affected
- Supports logon simulation for both virtualized applications and desktops
- Tests if the entire VMware Horizon delivery infrastructure is working in concert
- Quick SaaS deployment – up and running in minutes
- Web-based monitoring console
- Intuitive dashboards for logon performance monitoring
- 7-day historical reporting allows analyzing performance trends
- Optimized for VMware Horizon 7.x environments
The eG Enterprise Express Free Logon Simulator for Citrix and VMware Horizon is available now. Register on the eG Innovations website to get started now.
On-site at VMworld 2017 Europe in Barcelona: Get a live demo of eG Enterprise Express in booth #E526, and register to win a Google Home.
About eG Innovations
eG Innovations is dedicated to helping businesses across the globe transform IT service delivery into a competitive advantage and a center for productivity, growth and profit. Many of the world's largest businesses use eG Enterprise to enhance IT service performance, increase operational efficiency, ensure IT effectiveness and deliver on the ROI promise of transformational IT investments across physical, virtual and cloud environments. Visit us at www.eginnovations.com or on Twitter at @eGInnovations.
All trademarks, service marks and company names are the property of their respective owners.
For eG Innovations
Erin Farrell Talbot, 917-232-9309
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 20:37 | Pressemelding
Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f
Pharnext to Showcase PLEOTHERAPY™ R&D Platform at the 8th Annual Global Orphan Drug Conference19.4.2018 15:45 | Pressemelding
Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big data genomics and artificial intelligence, today announced that Rodolphe Hajj, Ph.D., the Company’s Chief Pharmacology Officer, will present at the 8th Annual Global Orphan Drug Conference. The presentation will take place as follows: Date & Time: Wednesday April 25th at 4:40 pm EST Title: “Next generation drug repurposing using network pharmacology to develop new therapeutic entities for rare diseases” Venue: Gaylord National Harbor Hotel, Oxon Hill, MD, U.S. Pharnext’s team will also attend the 2018 American Academy of Neurology Annual Meeting as a first-time exhibitor (booth 908). The meeting will take place on April 21-27, 2018 in Los Angeles, CA, U.S. If you are interested in meeting the Pharnext management team during these events, please send an email to firstname.lastname@example.org. About Pharnext Pharne
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices19.4.2018 15:01 | Pressemelding
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion best practices as part of post-operative patient blood management (PBM).1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419005949/en/ Masimo Radical-7® with SpHb® and RD rainbow SET™ Sensor (Photo: Business Wire) In the study, Prof. Baricchi and colleagues in the Transfusion Medicine Unit, AUSL-IRCCS of Reggio Emilia and at the Department of Medicine and Surgery at the University of Parma, Italy, sought to evaluate the appropriateness of post-operative RBC transfusion over a three-year period (2013-2015), before and after implementation of a patient blood managem
Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform19.4.2018 14:06 | Pressemelding
Synteract, an innovative contract research organization (CRO) providing full-service, Phase I-IV services to biopharma companies bringing new medicines to market, has enhanced its focus. The CRO today announced the creation of therapeutic centers of development that include some of the most progressive in the biopharma industry: oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease. In addition, Synteract revealed its new market positioning with an updated logo, tagline, and website to reinforce its core capabilities. Synteract’s leadership has been proven in these core development areas, over its nearly 30-year history, through its contributions to more than 240 product approvals. Formal establishment of its new centers of development bring more visibility to Synteract’s longstanding, specialized expertise in these complex areas of clinical research. Synteract CEO Steve Powell says, “By aligning operational excel
Nel ASA: Receives Additional Purchase Order from Nikola19.4.2018 14:00 | Pressemelding
Nel ASA (Nel, OSE: NEL) has received a USD 5.5 million purchase order from Nikola Motor Company (Nikola), as part of the previously announced hydrogen stations. “We are very proud to announce that we have received an additional order from Nikola related to the electrolyzer and fueling solution for their prototype trucks. The order marks a strengthening of our partnership and is a recognition of the level of competence our team and hydrogen solutions can offer. We look forward to supplying the demo stations, which will lay the groundwork for the world’s largest, most efficient network of low-cost hydrogen production and fueling sites,” says Jon André Løkke, Chief Executive Officer of Nel. On November 15, 2017, Nikola and Nel announced the exclusive partnership and a purchase order for two so-called demo hydrogen refueling stations for Nikola's fleet of prototype hydrogen trucks. The partnership aims at developing low-cost, renewable hydrogen production and fueling sites for the potentia
Voith and Franka Emika Form a Strategic Partnership19.4.2018 13:39 | Pressemelding
The technology company Voith and the Munich-based robotics company Franka Emika have entered into a strategic partnership. Part of the strategic partnership is the establishment of a new joint venture called Voith Robotics – A Voith and Franka Emika Company. The company, with headquarters in Munich, is to become a global system supplier for robot-assisted automation in the digital age. Voith Robotics will offer self-teaching lightweight robots made by Franka Emika, along with software solutions, apps, services and process consulting, to customers in various industries and markets throughout the world. As part of the strategic partnership Voith will also have a direct stake in Franka Emika, thus emphasizing the long-term and strategic commitment by the two companies to cooperation. Martin Scherrer, formerly a member of the Board of Management of Voith Paper, will be the new chief executive officer of Voith Robotics, which is to be managed by Voith. The still very young market for collab